Importantly, we identify the LINC02878/ZNF282/PYCR2 axis as a critical regulator of proline metabolism in CRC, unveiling its potential as a novel therapeutic target for precision intervention (Fig. 8G). The gene discussed is PYCR2; the disease is colorectal carcinoma.